Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.05
+0.25 (3.68%)
Sep 14, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 0.9 | 0.88 | 1.3 | 1.61 | 1.95 | 20.56 | 37.4 | 19.57 | 94.69 | 59.12 | 41.85 | 43.74 | 18.17 | 25.26 | - | - | - | - | - | - |
Revenue Growth | -53.95% | -95.74% | -96.53% | -91.75% | -97.94% | -65.23% | -10.63% | -55.25% | 421.16% | 134.05% | - | - | - | - | - | - | - | - | - | - |
Gross Profit Gross Profit Growth | -34.47 | -32.18 | -30.96 | -36.75 | -35.93 | -11.52 | 3.99 | -11.69 | 62.66 | 30.51 | 13.56 | 21.54 | -8.13 | 2.16 | -15.69 | -18.96 | -16.25 | -15.72 | -35.93 | - |
Operating Income Operating Income Growth | -44.96 | -42.3 | -40.31 | -47.05 | -46.85 | -21.79 | -5.87 | -21.66 | 53.42 | 21.11 | 4.91 | 14.01 | -16.3 | -5.78 | -25.58 | -25.94 | -23.58 | -22.15 | -18.46 | -14.36 |
Net Income Net Income Growth | -42.76 | -39.72 | -39.16 | -44.13 | -43.1 | -17.35 | 1.13 | -14.03 | 55.03 | 23.5 | -9.54 | 35.46 | -25.93 | -6.67 | -24.63 | -25.14 | -23.18 | -21.67 | -18.45 | -14.43 |
Earnings Per Share EPS Growth | -1.01 | -0.95 | -0.94 | -1.06 | -1.04 | -0.42 | 0.02 | -0.35 | 1.55 | 0.68 | -0.29 | 1.02 | -0.78 | -0.21 | -0.79 | -0.80 | -0.74 | -0.69 | -0.89 | -9.78 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 223.01 | 254.86 | 295.7 | 326.84 | 354.01 | 382.52 | 420 | 449.34 | 469.75 | 327.41 | 351.97 | 353.58 | 376.79 | 411.63 | 188.71 | 215.57 | 244.25 | 263.9 | 291.06 | 122.17 |
Total Debt Total Debt Growth | 48.54 | 49.75 | 50.93 | 52.4 | 54.74 | 57 | 59.21 | 61.31 | 64.44 | 66.43 | 68.23 | 69.07 | 73.03 | 16.23 | 25.94 | 27.95 | 29.92 | 31.86 | - | - |
Net Cash (Debt) Net Cash Growth | 174.46 | 205.11 | 244.77 | 274.44 | 299.27 | 325.52 | 360.79 | 388.03 | 405.3 | 260.98 | 283.74 | 284.51 | 303.76 | 395.41 | 162.78 | 187.62 | 214.34 | 232.05 | 291.06 | 122.17 |
Net Cash Growth | -41.70% | -36.99% | -32.16% | -29.27% | -26.16% | 24.73% | 27.16% | 36.39% | 33.43% | -34.00% | 74.31% | 51.64% | 41.72% | 70.40% | -44.08% | 53.57% | 56.51% | 494.30% | 645.46% | - |
Net Cash Per Share Net Cash Per Share Growth | 4.13 | 4.90 | 5.88 | 6.62 | 7.24 | 7.93 | 8.38 | 9.55 | 11.41 | 7.50 | 8.50 | 8.18 | 9.16 | 12.21 | 5.19 | 5.99 | 6.85 | 7.43 | 14.01 | 82.82 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -32.46 | -41.7 | -32.2 | -28.31 | -29.49 | -38.51 | -31.61 | -24.27 | 39.83 | -25.52 | -4.01 | -24.49 | -35.09 | 203.4 | -27.3 | -27.48 | -18.01 | -20.99 | -20.54 | -14.08 |
Capital Expenditures CapEx Growth | -0.01 | -0.04 | 0.21 | 0.17 | -0.28 | -1.14 | -0.64 | -0.64 | -1.05 | -0.84 | -0.98 | -1.45 | -1.52 | -1.67 | -0.71 | -0.81 | -0.78 | -0.59 | -1.32 | -0.81 |
Free Cash Flow Free Cash Flow Growth | -32.47 | -41.74 | -32 | -28.14 | -29.76 | -39.65 | -32.24 | -24.91 | 38.79 | -26.36 | -4.99 | -25.94 | -36.61 | 201.73 | -28.01 | -28.29 | -18.78 | -21.59 | -21.86 | -14.88 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | - | - | - | - | - | -56.02% | 10.67% | -59.72% | 66.17% | 51.61% | 32.40% | 49.26% | -44.74% | 8.54% | - | - | - | - | - | - |
Operating Margin | -5007.02% | -4834.63% | -3103.00% | -2915.18% | -2402.51% | -105.99% | -15.69% | -110.67% | 56.42% | 35.71% | 11.72% | 32.04% | -89.70% | -22.88% | - | - | - | - | - | - |
Pretax Margin | -4758.13% | -4534.74% | -3007.85% | -2693.93% | -2201.28% | -84.39% | -1.98% | -81.21% | 61.03% | 42.84% | 21.98% | 41.30% | -66.49% | -12.36% | - | - | - | - | - | - |
Profit Margin | -4762.03% | -4539.09% | -3014.93% | -2734.45% | -2210.41% | -84.39% | 3.02% | -71.70% | 58.12% | 39.74% | -22.81% | 81.08% | -142.70% | -26.42% | - | - | - | - | - | - |
FCF Margin | -3616.26% | -4770.17% | -2463.13% | -1743.62% | -1526.36% | -192.87% | -86.21% | -127.26% | 40.96% | -44.58% | -11.92% | -59.31% | -201.50% | 798.62% | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | - | 9.33 | - | 4.79 | 19.51 | - | - | - | - | - | - | - | - | - | - |
P/FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.79 | - | - | - | - | - | - |
PS Ratio | 56.60 | 79.18 | 14.50 | 3.35 | 2.98 | 1.87 | 2.90 | 2.61 | 2.09 | 2.81 | 3.90 | 6.03 | 11.57 | 18.99 | - | - | - | - | - | - |